Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Assets Average (2020 - 2025)

Pulmonx (LUNG) has disclosed Assets Average for 6 consecutive years, with $142.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 16.05% to $142.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $142.7 million, a 16.05% decrease, with the full-year FY2024 number at $170.3 million, down 8.3% from a year prior.
  • Assets Average was $142.7 million for Q3 2025 at Pulmonx, down from $165.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $259.5 million in Q1 2021 to a low of $142.7 million in Q3 2025.
  • A 5-year average of $190.1 million and a median of $185.2 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 43.9% in 2021, then decreased 17.87% in 2022.
  • Pulmonx's Assets Average stood at $241.0 million in 2021, then fell by 17.87% to $197.9 million in 2022, then dropped by 8.36% to $181.4 million in 2023, then dropped by 8.97% to $165.1 million in 2024, then dropped by 13.56% to $142.7 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Assets Average are $142.7 million (Q3 2025), $165.1 million (Q4 2024), and $170.0 million (Q3 2024).